Company Directory
Top Insights
  • Contribute something unique about Galectin Therapeutics that may be helpful for others (ex. interview tips, choosing teams, unique culture, etc).

  • About

    Galectin Therapeutics looks to help patients with NASH cirrhosis and cancer. Galectin’s lead drug (GR-MD-02, or belapectin) is a galectin-3 inhibitor.

    2000
    Year Founded
    45
    # of Employees
    Headquarters

    Get Verified Salaries in your Inbox

    Subscribe to verified offers.You'll get the breakdown of compensation details by email. Learn More

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Featured Jobs

      No featured jobs found for Galectin Therapeutics